Is pubertal onset a risk factor for blindness and renal replacement therapy in childhood-onset type 1 diabetes in Japan?

Diabetes Care

Volumn 30, Issue 9, 2007, Pages 2338-2340

  Morimoto, Aya ^a   Nishimura, Rimei ^a,b   Matsudaira, Toru ^a   Sano, Hironari ^a   Tajima, Naoko ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADOLESCENT; ADULT; ARTICLE; BLINDNESS; CHILD; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JAPAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; ONSET AGE; PUBERTY; RENAL REPLACEMENT THERAPY; RISK FACTOR;

ADOLESCENT; AGE OF ONSET; BLINDNESS; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INCIDENCE; MALE; RENAL REPLACEMENT THERAPY; RISK FACTORS;

EID: 34548395466     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-0043     Document Type: Article

References (20)

1. Nishimura R, Tajima N, Matsushima M, LaPorte RE, the Diabetes Epidemiology Research International Study Group: Puberty, IDDM, and death in Japan. Diabetes Care 21:1674-1979, 1998
2. Kostraba JN, Dorman JS, Orchard TJ, Becker DJ, Ohki Y, Ellis D, Doft BH, Lobes LA, LaPorte RE, Drash AL: Contribution of diabetes duration before puberty to development of microvascular complications in IDDM subjects. Diabetes Care 12:686-693, 1989
3. Olsen BS, Sjolie AK, Hougaard P, Johannesen J, Marinelli K, Jacobsen BB, Mortensen HB; Danish Study Group of Diabetes in Childhood: The significance of the prepubertal diabetes duration for the development of retinopathy and nephropathy in patients with type 1 diabetes. J Diabetes Complications 18:160-164, 2004
4. Dahlquist G, Rudberg S: The prevalence of microalbuminuria in diabetic children and adolescents and its relation to puberty. Acta Paediatr Scand 76:795-800, 1987
5. McNally PG, Raymond NT, Swift PG, Hearnshaw JR, Burden AC: Does the prepubertal duration of diabetes influence the onset of microvascular complications? Diabet Med 10:906-908, 1993
6. Donaghue KC, Fung AT, Hing S, Fairchild J, King J, Chan A, Howard NJ, Silink M: The effect of prepubertal diabetes duration on diabetes: microvascular complications in early and late adolescence. Diabetes Care 20:77-80, 1997
7. Svensson M, Nystrom L, Schon S, Dahlquist G: Age at onset of childhood-onset type 1 diabetes and the development of end-stage renal disease: a nationwide population-based study. Diabetes Care 29:538-542, 2006
8. Diabetes Epidemiology Research International Mortality Study Group: Major cross-country differences in risk of dying for people with IDDM. Diabetes Care 14:49-54, 1991
9. Asao K, Sarti C, Forsen T, Hyttinen V, Nishimura R, Matsushima M, Reunanen A, Tuomilehto J, Tajima N: Long-term mortality in nationwide cohorts of childhood-onset type 1 diabetes in Japan and Finland. Diabetes Care 26:2037-2042, 2003
10. Porta M, Dalmasso P, Grassi G, Marena S, Maurino M, Passera P, Trento M: Pre-pubertal onset of type 1 diabetes and appearance of retinopathy. Diabetes Metab 30:229-233, 2004
11. Kostraba JN, Dorman JS, LaPorte RE, Kuller LH, Orchard TJ, Becker DJ, Drash AL: The investigation of age at onset as a risk factor for mortality in persons with insulin-dependent diabetes mellitus using Cox proportional hazards models. Am J Epidemiol 133:67-72, 1991
12. Tajima N, LaPorte RE, Hibi I, Kitagawa T, Fujita H, Drash AL: A comparison of the epidemiology of youth-onset insulin-dependent diabetes mellitus between Japan and the United States (Allegheny County, Pennsylvania) Diabetes Care 8 (Suppl 1):17-23, 1985
13. Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane WV: Impaired insulin action in puberty: a contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med 315:215-219, 1986
14. Acerini CL, Williams RM, Dunger DB: Metabolic impact of puberty on the course of type 1 diabetes. Diabetes Metab 27:S19-S25, 2001
15. Simpson HL, Jackson NC, Shojaee-Moradie F, Jones RH, Russell-Jones DL, Sonksen PH, Dunger DB, Umpleby AM: Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetes. J Clin Endocrinol Metab 89:425-432, 2004
16. Amin R, Williams RM, Frystyk J, Umpleby M, Matthews D, Orskov H, Dalton RN, Dunger DB: Increasing urine albumin excretion is associated with growth hormone hypersecretion and reduced clearance of insulin in adolescents and young adults with type 1 diabetes: the Oxford Regional Prospective Study. Clin Endocrinol (Oxf) 62:137-144, 2005
17. Amin R, Schultz C, Ong K, Frystyk J, Dalton RN, Perry L, Orskov H, Dunger DB: Low IGF-I and elevated testosterone during puberty in subjects with type 1 diabetes developing microalbuminuria in comparison to normoalbuminuric control subjects: the Oxford Regional Prospective Study. Diabetes Care 26:1456-1461, 2003
18. Cummings EA, Sochett EB, Dekker MG, Lawson ML, Daneman D: Contribution of growth hormone and IGF-I to early diabetic nephropathy in type 1 diabetes. Diabetes 47:1341-1346, 1998
19. Hovind P, Lamberts S, Hop W, Deinum J, Tarnow L, Parving HH, Janssen JA: An IGF-I gene polymorphism modifies the risk of developing persistent microalbuminuria in type 1 diabetes. Eur J Endocrinol 156:83-90, 2007
20. Schultz CJ, Konopelska-Bahu T, Dalton RN, Carroll TA, Stratton I, Gale EA, Neil A, Dunger DB, the Oxford Regional Prospective Study Group: Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Diabetes Care 22:495-502, 1999